Journal articles on the topic 'Myers, Kevin'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 47 journal articles for your research on the topic 'Myers, Kevin.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Macpherson, Jim. "Struggles for a Past: Irish and Afro-Caribbean Histories in England, 1951–2000. By Kevin Myers." Twentieth Century British History 30, no. 4 (September 18, 2018): 618–20. http://dx.doi.org/10.1093/tcbh/hwy030.
Full textGerrard, Jessica. "Struggles for a past: Irish and Afro-Caribbean histories in England, 1951–2000, by Kevin Myers." History of Education 46, no. 4 (May 9, 2016): 533–34. http://dx.doi.org/10.1080/0046760x.2016.1181798.
Full textArriens, C., A. Askanase, R. Furie, E. F. Morand, R. Van Vollenhoven, K. Connors, M. Davey, et al. "AB0530 DESIGN OF 2 PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL TRIALS OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1463.1–1463. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3881.
Full textChoy, E., S. Henning, M. Brazil, K. Pollock, L. Groves, D. Sugrue, and J. Houghton. "AB0347 TREATMENT RESPONSE WITH ABATACEPT PLUS METHOTREXATE TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1299.1–1299. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2356.
Full textCurtis, J., K. Winthrop, B. Chan, S. Siegel, J. Stark, R. Suruki, R. Bohn, et al. "FRI0314 ANNUAL DIAGNOSTIC PREVALENCE OF ANKYLOSING SPONDYLITIS (AS) IN THE UNITED STATES USING MEDICARE AND MARKETSCAN DATA." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 747.1–748. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4246.
Full textKorman, N. J., T. Passeron, K. B. Gordon, Y. Okubo, J. Bagel, H. Sofen, R. B. Warren, et al. "AB1098 DEUCRAVACITINIB IN PLAQUE PSORIASIS: 2-YEAR LABORATORY RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1774–75. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1533.
Full textDeodhar, A., K. Winthrop, R. Bohn, B. Chan, R. Suruki, J. Stark, H. Yun, S. Siegel, L. Chen, and J. Curtis. "SAT0370 TUMOUR NECROSIS FACTOR INHIBITOR THERAPY DOES NOT REDUCE THE INCIDENCE OF COMORBIDITIES AND EXTRA-ARTICULAR MANIFESTATIONS IN ANKYLOSING SPONDYLITIS: AN ANALYSIS OF THREE US CLAIMS DATABASES." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1132.1–1133. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4201.
Full textWinthrop, K., P. Nash, K. Yamaoka, E. Mysler, L. Calabrese, N. Khan, J. J. Enejosa, Y. Song, J. Suboticki, and J. R. Curtis. "THU0218 INCIDENCE AND RISK FACTORS FOR HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING UPADACITINIB." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 335–36. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2744.
Full textAletaha, D., P. J. Mease, R. Lippe, F. Behrens, D. Haaland, P. Palominos, A. Lertratanakul, et al. "POS1026 PREDICTORS FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT WEEK 56 IN PATIENTS WITH PSORIATIC ARTHRITIS WHO RECEIVED UPADACITINIB 15 MG ONCE DAILY: POOLED ANALYSIS OF TWO PHASE 3 STUDIES." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 824.2–825. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1291.
Full textBaraliakos, X., R. Ranza, A. Ostor, F. Ciccia, L. Coates, S. Rednic, J. A. Walsh, et al. "POS0934 EFFICACY OF UPADACITINIB ON PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT DEFINED BY INVESTIGATOR ASSESSMENT AND PRO-BASED CRITERIA: RESULTS FROM TWO PHASE 3 STUDIES." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 768. http://dx.doi.org/10.1136/annrheumdis-2022-eular.722.
Full textRoth, Andreas. "Francis Stuart’s broadcasts from Germany, 1942—4: some new evidence." Irish Historical Studies 32, no. 127 (May 2001): 408–22. http://dx.doi.org/10.1017/s002112140001508x.
Full textGottlieb, A. B., F. Behrens, P. Nash, J. F. Merola, K. Ding, P. Pellet, L. Pricop, and I. Mcinnes. "FRI0340 COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 763.2–764. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4736.
Full textLininger, N., S. Siegel, S. Kiwalkar, K. Winthrop, A. Ortega Loayza, and A. Deodhar. "FRI0555 DO TNF INHIBITORS DECREASE RISK OF INCIDENT PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS COMPARED TO THOSE TREATED WITH METHOTREXATE ALONE?" Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 879.2–880. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4983.
Full textTurnage, Richard H., John L. Lanoue, Kevin M. Kadesky, Yan Meng, and Stuart I. Myers. "Thromboxane A2 mediates increased pulmonary microvascular permeability after intestinal reperfusion." Journal of Applied Physiology 82, no. 2 (February 1, 1997): 592–98. http://dx.doi.org/10.1152/jappl.1997.82.2.592.
Full textStefanovska, Bojana, Kevin Lin, Benjamin Troness, Chad Myers, and Reuben Harris. "Abstract P2-17-01: Targeted CRISPR screen to identify synthetic lethal combinations between APOBEC3B and DNA repair." Cancer Research 83, no. 5_Supplement (March 1, 2023): P2–17–01—P2–17–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p2-17-01.
Full textMcinnes, I., F. Behrens, P. J. Mease, A. Kavanaugh, C. T. Ritchlin, P. Nash, J. Gratacos-Masmitja, et al. "OP0227 SECUKINUMAB VERSUS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 52-WEEKS (EXCEED): A RANDOMISED, DOUBLE-BLIND, PHASE-3B STUDY." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 142–43. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4129.
Full textGenovese, M. C., K. Winthrop, Y. Tanaka, T. Takeuchi, A. Kivitz, F. Matzkies, L. Ye, et al. "THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 324–25. http://dx.doi.org/10.1136/annrheumdis-2020-eular.267.
Full textBykerk, V., A. B. Gottlieb, K. Reich, Y. Tanaka, K. Winthrop, C. Popova, N. Tilt, and A. Blauvelt. "FRI0087 DURABILITY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIASIS OVER THREE YEARS: AN ANALYSIS OF POOLED CLINICAL TRIAL DATA." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 621.1–621. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1682.
Full textKITLV, Redactie. "Book Reviews." New West Indian Guide / Nieuwe West-Indische Gids 62, no. 3-4 (January 1, 1988): 165–209. http://dx.doi.org/10.1163/13822373-90002043.
Full textMease, P. J., A. Kavanaugh, D. D. Gladman, O. Fitzgerald, E. Soriano, P. Nash, D. Feng, et al. "AB0529 CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 1294–95. http://dx.doi.org/10.1136/annrheumdis-2021-eular.574.
Full textHirano, A., W. Fujii, A. Sakashita, K. Baßler, M. Kadoya, A. Omoto, W. Fukuda, et al. "POS0151 SINGLE-CELL RNA SEQUENCING OF BRONCHOALVEOLAR LAVAGE FLUID AND BLOOD REVEALS DISEASE-SPECIFIC CHARACTERISTICS OF IMMUNE CELLS IN CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE PATIENTS." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 296–97. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2875.
Full textKavanaugh, A., P. J. Mease, K. Douglas, F. Behrens, D. Haaland, P. Palominos, A. Lertratanakul, et al. "AB0547 ASSOCIATION BETWEEN ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH IMPROVEMENT IN QUALITY OF LIFE IN UPADACITINIB-TREATED PATIENTS IN THE PHASE 3 SELECT-PsA 1 AND 2 STUDIES." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 1306.2–1307. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2000.
Full textMerola, J. F., I. Mcinnes, A. Kavanaugh, P. Nash, Z. Xue, V. Stakias, A. Eldred, S. Ciecinski, K. Douglas, and L. Coates. "POS1029 EFFECTS OF TREATMENT WITH RISANKIZUMAB ON MINIMAL DISEASE ACTIVITY (MDA) AND DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA): AN ANALYSIS OF THE KEEPsAKE-1 AND -2 TRIALS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 827. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1362.
Full textMerrill, J. T., M. Smith, K. Thomas, C. Guthridge, N. Dominguez, S. Macwana, W. Dejager, et al. "POS1154 PRE-TREATMENT DIFFERENTIALLY EXPRESSED METAGENES CHARACTERIZE SYSTEMIC LUPUS PATIENTS WHO SUBSEQUENTLY ACHIEVE CLINICAL RESPONSE TO BELIMUMAB." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 908–9. http://dx.doi.org/10.1136/annrheumdis-2023-eular.4022.
Full textFujii, W., A. Sakashita, A. Hirano, K. Baßler, M. Kadoya, A. Omoto, W. Fukuda, et al. "POS0616 THE CHARACTERISTICS OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE IN CONNECTIVE TISSUE DISEASES WITH SINGLE-CELL RNA SEQUENCING OF BRONCHOALVEOLAR LAVAGE FLUID." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 580.1–581. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2140.
Full textGalloway, J., M. H. Buch, K. Yamaoka, C. Leatherwood, A. Pechonkina, I. Tiamiyu, D. Jiang, et al. "OP0126 INFECTIONS AND SERIOUS INFECTIONS IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 70–71. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1416.
Full textCostello, R. E., J. Humphreys, K. Winthrop, and W. Dixon. "SAT0065 TIMING OF PNEUMOCOCCAL VACCINATIONS IN RELATION TO STARTING DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 965.1–966. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1157.
Full textGenovese, M. C., J. S. Smolen, T. Takeuchi, G. R. Burmester, W. Deberdt, D. Schlichting, H. Song, D. Mo, C. Walls, and K. Winthrop. "FRI0123 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 642.1–643. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1723.
Full textWinter, Timothy, Timothy Myers, Leandro Colli, Lea Jessop, Jiyeon Choi, Mitchell J. Machiela, Mark P. Purdue, Kevin Brown, and Stephen Chanock. "Abstract 6154: Targeted CRISPRi screen identifies functional variants and novel target genes at multiple renal cell carcinoma (RCC) susceptibility loci." Cancer Research 84, no. 6_Supplement (March 22, 2024): 6154. http://dx.doi.org/10.1158/1538-7445.am2024-6154.
Full textWinthrop, K., D. Gold, D. Henrohn, L. Wang, A. Shapiro, H. Shi, G. Citera, and H. Schulze-Koops. "SAT0139 AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIES." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1007–8. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1432.
Full textThakur, Rohit, Mai Xu, Alexandra Thornock, Hayley Sowards, Epring Long, Thomas Rheling, Karen Funderburk, et al. "Abstract 5239: Integrative analysis of 3D chromatin organization at GWAS loci identifies RAPGEF1 as a melanoma susceptibility gene." Cancer Research 83, no. 7_Supplement (April 4, 2023): 5239. http://dx.doi.org/10.1158/1538-7445.am2023-5239.
Full textHu, Fang Q., and Douglas M. Nark. "On a stabilization of the Ingard-Myers impedance boundary condition and its time domain implementation." International Journal of Aeroacoustics 23, no. 3-4 (May 9, 2024): 318–41. http://dx.doi.org/10.1177/1475472x241230649.
Full textRims, C., V. Muir, K. Deane, S. Nagpal, N. Rao, F. Baribaud, G. Vratsanos, et al. "THU0033 ALTERATIONS IN THE PHENOTYPIC LANDSCAPE AND SPECIFICITY OF CD4+ T CELLS IN CCP+ AT RISK SUBJECTS BEFORE THE ONSET OF RHEUMATOID ARTHRITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 230.1–230. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1918.
Full textBurmester, G. R., K. Winthrop, R. Blanco, P. Nash, P. Goupille, V. F. Azevedo, C. Salvarani, et al. "AB0522 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS FROM THE PHASE 3 PROGRAM." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 1287–88. http://dx.doi.org/10.1136/annrheumdis-2021-eular.395.
Full textHu, Fang, and Douglas M. Nark. "A time domain boundary element method for acoustic scattering by lined surfaces in a subsonic uniform mean flow." Journal of the Acoustical Society of America 152, no. 4 (October 2022): A118. http://dx.doi.org/10.1121/10.0015737.
Full textAi, R., D. Boyle, D. Hammaker, K. Deane, V. M. Holers, A. Matti, W. Robinson, et al. "OP0337 DIFFERENTIAL METHYLATION OF PERIPHERAL BLOOD ADAPTIVE IMMUNE CELLS IN INDIVIDUALS AT HIGH RISK FOR RA AND WITH EARLY RA COMPARED WITH CONTROLS IDENTIFIES PATHWAYS IMPORTANT IN TRANSITION TO ARTHRITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 207.2–207. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2989.
Full textPolinski, K., E. Bemis, K. Demoruelle, J. Seifert, T. Crume, F. Yang, W. Robinson, et al. "SAT0596 ASSOCIATIONS BETWEEN CIRCULATING LIPID MEDIATORS AND INCIDENT INFLAMMATORY ARTHRITIS IN AN ANTI-CITRULLINATED PROTEIN ANTIBODY POSITIVE POPULATION." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1256.1–1256. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1884.
Full textJenkins, Rhys. "R. Evan Ellis, China on the Ground in Latin America: Challenges for the Chinese and Impacts on the Region (Basingstoke and New York: Palgrave Macmillan, 2014), pp. xiii + 320, £72.00, hb. - Kevin P. Gallagher, The China Triangle: Latin America's China Boom and the Fate of the Washington Consensus (Oxford and New York: Oxford University Press, 2016), pp. xvii + 232, £18.99; $27.95, hb. - Margaret Myers and Carol Wise (eds.), The Political Economy of China–Latin America Relations in the New Millennium: Brave New World (New York and London: Routledge, 2017), pp. vii + 293, £29.99, pb. - Yanran Xu, China's Strategic Partnerships in Latin America: Case Studies of China's Oil Diplomacy in Argentina, Brazil, Mexico, and Venezuela, 1991–2015 (Lanham, MD: Lexington Books, 2017), pp. ix + 157, £52.95, hb." Journal of Latin American Studies 51, no. 1 (February 2019): 187–91. http://dx.doi.org/10.1017/s0022216x19000014.
Full textLuo, Rui, Weelic Chong, Zhenchao Zhang, Maysa Abu-Khalaf, Daniel Silver, Frederick Fellin, Rebecca Jaslow, et al. "Abstract P5-06-05: Whole-genome bisulfite sequencing of single circulating tumor cells identifies cellular methylation heterogeneity in metastatic breast cancer." Cancer Research 83, no. 5_Supplement (March 1, 2023): P5–06–05—P5–06–05. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-06-05.
Full textKITLV, Redactie. "Book Reviews." New West Indian Guide / Nieuwe West-Indische Gids 70, no. 1-2 (January 1, 1996): 133–203. http://dx.doi.org/10.1163/13822373-90002634.
Full textHengel, Richard L., Sujatha Krishnan, Jonathan A. Rosenberg, Timothy E. Ritter, Kathy A. Baker, Lucinda J. Van Anglen, Amy Guo, Mielad Moosapanah, Min Yang, and Kevin W. Garey. "685. Early Experience with a Simple Administration of a Novel Fecal Microbiome Replacement for Prevention of Recurrent Clostridioides difficile." Open Forum Infectious Diseases 10, Supplement_2 (November 27, 2023). http://dx.doi.org/10.1093/ofid/ofad500.747.
Full text"Recensions / Reviews." Canadian Journal of Political Science 34, no. 4 (December 2001): 845–924. http://dx.doi.org/10.1017/s0008423901778110.
Full textRamos, Gabriel Teixeira. "CARTOGRAFIAS E MOVIMENTOS." Revista Jatobá 1 (December 18, 2019). http://dx.doi.org/10.54686/revjat.v1i.61326.
Full textCashman, Dorothy Ann. "“This receipt is as safe as the Bank”: Reading Irish Culinary Manuscripts." M/C Journal 16, no. 3 (June 23, 2013). http://dx.doi.org/10.5204/mcj.616.
Full textBrien, Donna Lee. "Demon Monsters or Misunderstood Casualties?" M/C Journal 24, no. 5 (October 5, 2021). http://dx.doi.org/10.5204/mcj.2845.
Full textWilson, Shaun. "Situating Conceptuality in Non-Fungible Token Art." M/C Journal 25, no. 2 (April 25, 2022). http://dx.doi.org/10.5204/mcj.2887.
Full textRyder, Paul, and Jonathan Foye. "Whose Speech Is It Anyway? Ownership, Authorship, and the Redfern Address." M/C Journal 20, no. 5 (October 13, 2017). http://dx.doi.org/10.5204/mcj.1228.
Full text